Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman FLX Left Atrial Appendage Closure (LAAC) Device.
News | Left Atrial Appendage (LAA) Occluders | July 22, 2020
FDA Clears Next-generation Watchman FLX Left Atrial Appendage Occluder
July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman...
read more
The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.

Figure 1: The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.

News | Hemodynamic Support Devices | July 16, 2020
FDA Clears Data Streaming From the Impella Console to Allow Use of Artificial Intelligence Algorithms 
July 16, 2020 – The U.S. Food and Drug Administration (FDA) approved one-way digital data streaming during patient...
read more
The impact of COVID-19 on the healthcare industry.

Getty images

News | Coronavirus (COVID-19) | July 16, 2020
Top 5 Predictions for the Global Healthcare Industry Post COVID-19
July 16, 2020 – Frost and Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020, forecasts...
read more
Videos | Cardiogenic Shock | July 15, 2020
VIDEO: New Research in Cardiogenic Shock at Tufts Medical Center
Navin Kapur, M.D., FAHA, FACC, FSCAI, director, Acute Mechanical Circulatory Support Program and executive director of...
read more
VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.
News | Hypertension | July 15, 2020
Omron and Mount Sinai Health Collaborate to Monitor High-risk Patient Blood Pressure at Home
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...
read more
The Edwards Konect Resilia aortic valved conduit (AVC).
News | Heart Valve Technology | July 15, 2020
FDA Clears Edwards Konect Resilia Aortic Valved Conduit For Complex Aortic Valve Surgeries
July 15, 2020 —  The U.S. Food and Drug Administration (FDA) granted clearance for the Edwards Lifesciences Corp....
read more
The American Heart Association (AHA) has cancelled its in-person annual meeting due to COVID-19 and plans to host a virtual, online meeting instead.

The American Heart Association (AHA) has cancelled its in-person annual meeting due to COVID-19 and plans to host a virtual, online meeting instead.

News | AHA | July 15, 2020
AHA Annual Meeting Goes Virtual Due to COVID-19
July 15, 2020 – The last major cardiovascular conference to go virtual in 2020 due to the COVID-19 (SARS-Cov-2)...
read more
A comparison of the Edwards Pascal (left) and the Abbott MitraClip used for transcatheter mitral and tricuspid valve leaflet repairs. The two companies settled patent litigation regarding the devices today.
News | Structural Heart | July 13, 2020
Edwards Lifesciences and Abbott Settle Transcatheter Mitral Valve Device Patent Litigation
July 13, 2020 — Edwards Lifesciences Corp. and Abbott Vascular announced the two companies have reached an agreement to...
read more
Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
The Strategic Role of Ambulatory Surgery Centers Cardiology Care
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant....
read more
A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

News | Stroke | July 09, 2020
Society for Vascular Surgery Outlines What is Needed for Trans-Carotid Artery Revascularization Training and Credentialing
July 9, 2020 — The Society for Vascular Surgery (SVS) has released a clinical competence statement on training and...
read more
News | Heart Failure | July 09, 2020
Novel Hydrogel May Help Repair Cardiac Tissue
July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel...
read more
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
Philips and Leeds Teaching Hospitals NHS Trust Partner on New Standards For Integrated Cardiac Care
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service...
read more
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

News | Coronavirus (COVID-19) | July 07, 2020 | Dave Fornell, Editor
American Heart Association Denounces Threats to Public Health Leaders Responding to the COVID-19 Pandemic 
July 7, 2020 — In the face of the coronavirus pandemic, public health officials worldwide are working tirelessly to...
read more
Three of the most popular cardiovascular technologies to make news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made s

Three of the most popular cardiovascular technologies to make the top news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made structural heart devices to gain European CE mark approval.

Feature | July 06, 2020
Most Popular Cardiology Technology Content in June 2020
July 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
read more
The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach
News | Cardiovascular Clinical Studies | July 01, 2020
Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder
July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (...
read more
© Copyright Wainscot Media. All Rights Reserved.